Lexeo Therapeutics Inc — Quarterly Cash Flow (NASDAQ:LXEO) | MetaTrader

Open full chart

Financials

Overview Finanzbericht Statistics Dividends

Quarterly Annual

Total assets 173.87 M146.94 M125.69 M176.07 M143.84 M Total liabilities 34.54 M30.1 M37.58 M37.85 M23.01 M Total equity 139.33 M116.84 M88.11 M138.22 M120.83 M Total liabilities & shareholders' equities 173.87 M146.94 M125.69 M176.07 M143.84 M Total debt ————— Net debt —————

Nachrichten

Lexeo Therapeutics, Inc. (LXEO) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 Transcript

Lexeo Therapeutics besetzt COO- und CMO-Posten neu

Lexeo Therapeutics stellt Führungsteam neu auf und ernennt Chief Medical Officer

Lexeo Therapeutics announces key leadership appointments

Lexeo Therapeutics, Inc. (LXEO) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:LXEO) 2026-01-14

Lexeo Therapeutics, Inc. (LXEO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Oppenheimer reiterates Outperform rating on Lexeo Therapeutics stock

Lexeo Therapeutics: Aktie stürzt trotz bestätigtem ’Overweight’-Rating um 23 % ab

Lexeo Therapeutics stock falls 23% despite Cantor maintaining Overweight rating

H.C. Wainwright senkt Kursziel für Lexeo Therapeutics wegen Bedenken bei PKP2-Daten

H.C. Wainwright lowers Lexeo Therapeutics stock price target on PKP2 data concerns

Five Below To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Tuesday - American Eagle Outfitters (NYSE:AEO), Apellis Pharmaceuticals (NASDAQ:APLS)